Background Neonatal hypoxic-ischemic encephalopathy (HIE) affects as many as 100,000
infants each year in China. Therapeutic hypothermia reduces HIE related mortality and long …

Importance Hypoxic-ischemic encephalopathy (HIE) occurs in 1 to 8 per 1000 live births in
developed countries. Historically, the clinician has had little to offer neonates with HIE other …

Background Hypoxic ischemic encephalopathy (HIE) is a significant cause of mortality and
short-and long-term morbidities. Therapeutic hypothermia (TH) has been shown to be the …

Objective To characterize variations in practices and outcomes for neonates with hypoxic-
ischemic encephalopathy (HIE) treated with therapeutic hypothermia (TH) across Canadian …

Objective To compare the characteristics and outcomes of neonates with mild hypoxic-
ischemic encephalopathy (HIE) who received hypothermia versus standard care. Study …

Despite advances in obstetric care, hypoxic ischemic encephalopathy (HIE) remains a
significant disease burden. We determined the national trends of HIE prevalence …

Objective Hypoxic-ischaemic encephalopathy (HIE) remains a leading cause of neonatal
mortality and neurodisability. We aimed to determine the incidence of HIE and management …

Aims Hypoxic ischaemic encephalopathy (HIE) remains a significant cause of long term
neurodisability despite therapeutic hypothermia (TH). Infants with mild HIE, representing …

Introduction: Accurately diagnosing and treating infants with mild forms of hypoxic ischemic
encephalopathy (HIE) is important, as the majority of neonates with signs and symptoms of …

Abstract Aim This South African study documented the survival and neurodevelopmental
outcomes of infants with hypoxic‐ischaemic encephalopathy (HIE) after introducing cooling …